Showing results (161-170 of 529) with videos related to
Sort By:
Pageof 53
Circulation|January 7, 1997
Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseasesJ B Knox, G K Sukhova, A D Whittemore, et al.Circulation|November 7, 2001
Soluble CD40L and cardiovascular risk in womenU Schönbeck, N Varo, P Libby, et al.The Journal of Clinical Investigation|December 1, 1994
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaquesZ S Galis, G K Sukhova, M W Lark, et al.The Australian Journal of Experimental Biology and Medical Science|April 1, 1984
Organotin implications in anticarcinogenesis. Effects of several organotins on tumour growth rate in miceN F Cardarelli, B M Cardarelli, E P Libby, et al.Nature|July 22, 1998
Reduction of atherosclerosis in mice by inhibition of CD40 signallingF Mach, U Schönbeck, G K Sukhova, et al.Arteriosclerosis (Dallas, Tex.)|March 1, 1985
Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cellsP Libby, D J Wyler, M W Janicka, et al.Thrombosis and Haemostasis|January 13, 2011
Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivoT Quillard, K Croce, F A Jaffer, et al.The American Journal of Pathology|July 17, 1998
Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cellsS Hasegawa, G Becker, H Nagano, et al.Circulation|June 22, 1999
PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cellsN Marx, G K Sukhova, T Collins, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosisK Shimizu, U Schönbeck, F Mach, et al.Pageof 53